Lead Story
EMA launches #HealthNotHype campaign
This industry news update shares the EMA’s new social media campaign to raise awareness for GLP-1 medicines.
Industry news
MHRA cuts approval times for UK clinical trials in half
This industry news update announces the MHRA’s decision to reduce clinical trial approvals from 91 days to 41 days.
NICE reviews health technology assessment to better support patients
This industry news update shares NICE’s plans to review how health technologies are evaluated.
Regulatory Rapporteur is back in PDF format
News of an exciting new development for Regulatory Rapporteur starting in October 2025.
MHRA cross-agency team outlines emerging considerations for the manufacture of personalised medicines
This industry news update shares the MHRA’s guidance for the manufacture of personalised medicines.
AI Airlock: Growing the future of artificial intelligence technology in healthcare
This industry news update is about the ongoing projects as a part of AI Airlock led by the MHRA.
NICE increases access to SGLT-2 inhibitors medicines to help treat type 2 diabetes
This industry news update is on SGLT-2 inhibitors that NICE are expanding access for as an alternative treatment for type 2 diabetes.
More news
Survey shapes Regulatory Rapporteur’s future plans
EFPIA publishes guidance document to help support novel methodology submissions
New Director appointed at the FDA’s Center for Drug Evaluation and Research
FDA makes labelling changes to opioid products mandatory
EMA publishes workplan on how to harness data and AI for public health
EMA and ICH call for more real-world evidence in regulatory practices
NICE rejects funding for Lecanemab as treatment benefits ‘remain too small’
